These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 193801)

  • 1. Neutralizing EBV-specific IgA in throat washings of nasopharyngeal carcinoma (NPC) patients.
    Desgranges C; De-Thé G; Ho JH; Ellouz R
    Int J Cancer; 1977 May; 19(5):627-33. PubMed ID: 193801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.
    Henle G; Henle W
    Int J Cancer; 1976 Jan; 17(1):1-7. PubMed ID: 175020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
    Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA and nasopharyngeal carcinoma.
    Desgranges C; De-The G
    IARC Sci Publ (1971); 1978; (24 Pt 2):883-91. PubMed ID: 221410
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of plasma IgA and IgG antibodies to Epstein-Barr virus early and viral capsid antigens in Thai nasopharyngeal carcinoma.
    Tiwawech D; Srivatanakul P; Karaluk A; Ishida T
    Asian Pac J Cancer Prev; 2003; 4(2):113-8. PubMed ID: 12875623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG and IgA antibodies to Epstein-Barr virus in nasopharyngeal carcinoma patients.
    Gong SH; Lynn TC; Yang CS
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1978 Mar; 11(1):8-15. PubMed ID: 211015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of virus-specific antibodies to EBV-antigens in patients with nasopharyngeal carcinoma (author's transl)].
    Wilmes E; Wolf H; Deinhardt F; Naumann HH
    Laryngol Rhinol Otol (Stuttg); 1979 Dec; 58(12):911-5. PubMed ID: 231716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased incidence of IgA antibodies to the Epstein-Barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia.
    Dölken G; Bross KJ; Hecht T; Brugger W; Löhr GW; Hirsch FW
    Int J Cancer; 1986 Jul; 38(1):55-9. PubMed ID: 3013785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [IgG- and IgA-antibodies to the Epstein-Barr virus in the sera of patients with nasopharyngeal carcinoma in Cuba].
    Gurtsevich VE; Ruíz García R; Cuevas J; Le Riverand Morales E; Ascue M
    Vopr Virusol; 1979; (4):392-9. PubMed ID: 225887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.
    Ho HC; Ng MH; Kwan HC; Chau JC
    Br J Cancer; 1976 Dec; 34(6):655-60. PubMed ID: 188437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Danish adult case of EBV-positive Burkitt's lymphoma.
    Laulund S; Elling F; Saemundsen AK
    Acta Pathol Microbiol Immunol Scand A; 1983 Jan; 91(1):77-80. PubMed ID: 6299057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
    Karray H; Ayadi W; Fki L; Hammami A; Daoud J; Drira MM; Frikha M; Jlidi R; Middeldorp JM
    J Med Virol; 2005 Apr; 75(4):593-602. PubMed ID: 15714486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT; Yeh CY
    Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of IgA specific antibodies to Epstein-Barr virus capsid and early antigens in nasopharyngeal carcinoma.
    Puthavathana P; Kositanont U; Chongkolwatana C; Metheetrairut C; Chantarakul N; Nuntarakchaikul S; Wasi C
    Asian Pac J Allergy Immunol; 1993 Jun; 11(1):39-43. PubMed ID: 8216557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBV specific secretory IgA in saliva of NPC patients. Presence of secretory piece in epithelial malignant cells.
    Desgranges C; Li JY; De-Thé
    Int J Cancer; 1977 Dec; 20(6):881-6. PubMed ID: 201574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of detection assays of Epstein-Barr viral Rta-IgG, VCA-IgA, EA-IgA and Epstein-Barr viral DNA at different clinical stages in the diagnosis of nasopharyngeal carcinoma].
    Luo YL; Chen H; Peng SG; Lin JH; Huang PY
    Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(44):3516-9. PubMed ID: 24521892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologic diagnosis of nasopharyngeal carcinoma. A double-blind study of four EB virus antibodies with evaluation by sequential discrimination.
    Cai WM; Li YW; Wu B; Liu YY; Hu YH; Gu XZ; Liu HY; Wang GD
    Int J Radiat Oncol Biol Phys; 1983 Dec; 9(12):1763-8. PubMed ID: 6319338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
    Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
    J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immune response in Epstein-Barr virus infections. I. Elevated serum concentration of the IgG1 subclass in infectious mononucleosis and nasopharyngeal carcinoma.
    Kaschka WP; Hilgers R; Skvaril F
    Clin Exp Immunol; 1982 Jul; 49(1):149-56. PubMed ID: 6290114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.